Find an expert

Dr Yousuf Mohammed completed his PhD in pharmaceutics and skin drug delivery under the guidance of Associate prof Heather Benson, Prof Michael Roberts and Associate prof Tarl Prow. He has been working within the field of skin delivery at the Therapeutics Research Centre, University of Queensland - School of Medicine since 2012. His current research includes managing a five-year (2018-2023) US FDA funded project titled Bioequivalence of Topical products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations as a Principle Investigator and managing the five-year project (2014-2019) Characterization of Critical Quality Attributes for Semisolid Topical Drug Products as a Co-investigator. These projects aims to improve current regulatory guidelines for topical and transdermal semisolid products. Over the last 6 years, his work has been focused on skin penetration and skin toxicology of drugs and xenobiotics including nanoparticulate materials.

Dr Devi Mohan, an Associate Professor in the School of Public Health is a physician with a specialization in Community Medicine and holds a Graduate Certificate in Higher Education.

Dr Mohan leads the public health teaching of the MD program and serves as the theme lead for Advocate for Health Improvement. She has extensive experience teaching in medical programs in both India and Malaysia, including integrated medical programs, and has mentored many medical graduates in medical research.

Dr Mohan's research primarily focuses on dementia epidemiology, prevention, and care in low and middle-income countries. Her work has been published in high impact public health and dementia journals. Currently, she leads various dementia research projects in Malaysia, Vietnam, and India. Working with various international research teams, Dr Mohan has secured research grants totalling over AUD 5 million from prestigious funding bodies such as NIHR UK, Australian Research Council, and MRC UK. She has mentored many PhD students and post-doctoral fellows, contributing to the development of the next generation of public health researchers.

As a member of the NIHR Global Health Group on Dementia Prevention and Enhanced Care (DePEC), Dr Mohan collaborates with international experts to develop approaches for reducing dementia risk and establishing sustainable care pathways. She has extensive international collaborations with partners in the UK, India, Malaysia, South-East Asia, focusing on projects related to aging and dementia. Dr Mohan is a member of Global Dementia Prevention Program, and the Southeast Asia Dementia Research Network.

Prior to her current role, Dr Mohan served as an Associate Professor in Global Public Health at the Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia. She has also worked with the Department of Health, Kerala, India, where she was actively involved in primary health care and delivery of health programs.

Dr Mollee practices as a consultant haematologist in clinical and laboratory haematology at the Princess Alexandra Hospital and is Associate Professor with the University of Queensland Medical School.

Having trained in Brisbane and Toronto, Dr Mollee has developed an international reputation studying amyloidosis and the plasma cell dyscrasias. He holds appointments with the Medical Scientific Advisory Group of Myeloma Australia, Australian Amyloidosis Network, National Blood Cancer Taskforce and is a member of the AACB Monoclonal Gammopathy Working Group and the International Kidney & Monoclonal Gammopathy Research Group. He is a past Chairman of the Australasian Leukaemia and Lymphoma Group (ALLG) and current Chair of the Australian Amyloidosis Network. He heads the Myeloma Service as well as the Queensland Amyloidosis Centre which runs one of the few clinics in Australia dedicated exclusively to the care of patients with amyloidosis.

Dr Tom Moloney is an ophthalmologist specialising in retinal and macular diseases, cataract surgery and vitreoretinal surgery.

Dr Moloney studied Medicine at the University of Queensland then completed specialist ophthalmology training in Queensland. He then undertook the Medical Retina and Uveitis Fellowship at the prestigious Moorfields Eye Hospital in London and subsequently returned to Brisbane to complete the Vitreoretinal Surgery Fellowship at the Royal Brisbane and Women’s Hospital. He was awarded the RANZCO Topham Scholarship to support his fellowship training in the United Kingdom.

He is a Fellow of the Royal Australian and New Zealand College of Ophthalmologists, a member of both the American Society of Retinal Specialists and the Australian and New Zealand Society of Retinal Specialists and a member of the American Society of Cataract and Refractive Surgeons.

Dr Moloney holds academic appointments at the University of Queensland and is involved with the teaching and training of medical students, optometrists and ophthalmology registrars.

Specialty Interests

Dr Moloney’s specialty interests include:

• Intravitreal injection and laser treatments for:
  • Age Related Macular Degeneration
  • Retinal Vein Occlusion
  • Diabetic Eye Disease
• Vitreoretinal surgery for:
  • Macular Hole
  • Epiretinal Membrane
  • Retinal Detachment
  • Secondary Intraocular Lens
• Cataract Surgery
• Pterygium Surgery

Dr Jayson Moloney is a colorectal surgeon and gastrointestinal endoscopist consulting and operating across Brisbane's north.

Jayson's clinical special interests include colorectal cancer, minimally-invasive (laparoscopic and robotic surgery) and complex pelvic surgery. He practices across the full breadth of colorectal surgery, including both benign and malignant disorders such as diverticular disease, inflammatory bowel disease, rectal prolapse and haemorrhoids.

In addition to private practice, Jayson also holds appointments as a colorectal surgeon at the Royal Brisbane and Women’s Hospital and is a Senior Lecturer with the University of Queensland.

Enquiries: admin@ausces.com or https://www.drjaysonmoloney.com.au/

Frank’s research interests include political behaviour, political communication, voter attitudes, behaviour change, leadership and evidence-based policy. His research has been published in leading international journals such as Leadership Quarterly, European Journal of Political Research, Political Psychology, Public Administration, West European Politics, Journal of Common Market Studies, Evidence and Policy, China Quarterly and the Australian Journal of Public Administration. His 2017 book The Wealth Paradox (co-authored with Jolanda Jetten and published by Cambridge University Press) has also attracted international attention, and is now widely regarded as having successfully debunked common myths about populist radical right parties and their voter base.

Literacy, teacher education, literacy and intellectual disability, teaching and learning in higher education

Associate Professor Karen Moni has had extensive experience teaching and researching in the field of English and literacy education. Her research interests include adolescent literacy and literature, literacy and young adults with intellectual disabilities, teacher education and teaching and learning in higher education. Dr Moni is also the Exectiuve Director of Latch-On a research and teaching program focusing on literacy and young adults with intellectual disabilities and continues to research in the area of intellectual disability

Dr Moni holds a PhD in Artificial Intelligence & Data Science in 2014 from the University of Cambridge, UK followed by postdoctoral training at the University of New South Wales, University of Sydney Vice-chancellor fellowship, and Senior Data Scientist at the University of Oxford. Dr Moni then joined UQ in 2021. He also worked as an assistant professor and lecturer in two universities (PUST and JKKNIU) from 2007 to 2011. He is an Artificial Intelligence, Computer Vision & Machine learning, Digital Health Data Science, Health Informatics and Bioinformatics researcher developing interpretable and clinical applicable machine learning and deep learning models to increase the performance and transparency of AI-based automated decision-making systems.

His research interests include quantifying and extracting actionable knowledge from data to solve real-world problems and giving humans explainable AI models through feature visualisation and attribution methods. He has applied these techniques to various multi-disciplinary applications such as medical imaging including stroke MRI/fMRI imaging, real-time cancer imaging. He led and managed significant research programs in developing machine-learning, deep-learning and translational data science models, and software tools to aid the diagnosis and prediction of disease outcomes, particularly for hard-to-manage complex and chronic diseases. His research interest also includes developing Data Science, machine learning and deep learning algorithms, models and software tools utilising different types of data, especially medical images, neuroimaging (MRI, fMRI, Ultrasound, X-Ray), EEG, ECG, Bioinformatics, and secondary usage of routinely collected data.

• I am currently recruiting graduate students. Check out Available Projects for details. Open to both Domestic and International students.

Gloria is a Lecturer in Chemical Engineering and an Advance Queensland Industry Research Fellow at UQ’s School of Chemical Engineering. She applies multiscale simulation techniques, combining molecular simulations with macroscopic physics-based modelling, to address energy and environmental challenges. Working at the interface of applied mathematics and engineering, she develops predictive models to understand complex system behaviour and computational methods to enhance simulation tools across chemical engineering applications.

Her expertise spans membrane science, nanocomposites, transport phenomena, and chemical kinetics, with a focus on adsorption, diffusion, and permeation in nanocomposites, as well as reaction engineering of complex chemical systems. She integrates Bayesian statistics, physical modelling, computational chemistry, and experimental validation to optimize carbon capture technologies for climate change mitigation and advance the development of sustainable chemical processes.

Professor Michael Monteiro has established an international reputation in the field of 'living' radical polymerization to create complex polymer architectures. He is now building designer polymers for various biomedical applications, including vaccines, drug delivery and stem cells. He is dedicated to translating research into commercial outcomes, with 7 PCT and provisional patents since 2005 and start-up company DendriMed Pty Ltd. He was awarded an ARC QEII Fellowship in 2004 and an ARC Future Fellowship in 2009. He has attracted ARC and NHMRC grants; and Queensland State Government funding in excess of $7 million.

International links

Professor Monteiro has built a strong collaboration with Professor Virgil Percec from the University of Pennsylvania to develop and understand the new SET-LRP. He has developed a collaboration with Professor Rachel O'Reilly from the University of Warwick to develop nanoreactors that mimic enzyme activity. In collaboration with Professor Eugenia Kumacheva from the University of Toronto, they developed temperature responsive micron-sized particles from encapsulation of cells.

Greg studies cellular signalling in disease and the identification of new drug targets. Greg leads the Calcium Signalling Therapeutics Team (CaSTT) in the School of Pharmacy and Pharmaceutical Sciences at UQ.

His lab specializes in the development and application of genetically encoded calcium indicators for high-content imaging in live cells. His team focuses on integrating these technologies into high-throughput assays that are critical for drug discovery efforts targeting calcium-mediated signaling pathways. The group has developed and utilized high-content imaging platforms to investigate calcium signaling in various cell types. These platforms enable the team to conduct large-scale screenings and these have been instrumental in identifying novel therapeutic targets.

Greg has established a research program with research funding via NHMRC, ARC, Queensland Cancer Council, Society of Biomolecular Screening, Department of Defense (USA) and other grants and collaboration with Pharmaceutical companies. His interests are signal transduction in disease, calcium transporters as drug targets and biomolecular screening. His work has led to patents and projects towards commercialization for new therapies for cancer.

In 2006 he received a UQ Foundation research excellence award and in 2016 he received the UQ Research Higher Degree Supervision Excellence Award - video link. Greg has also recieved a Research Mentorship Award (HaBS, 2017) and an award for Excellence in Leadership (UQ, 2016).

Dr Shehzahdi (Sheb) Moonshi is a nanobiologist and translational immunology researcher at the University of Queensland’s Frazer Institute and Translational Research Institute (TRI). Her research focuses on developing antigen-specific immunotherapies (ASI) and nanoparticle-based precision medicines to treat autoimmune diseases such as psoriatic arthritis and rheumatoid arthritis.

At TRI (2025), she has translated this skillset to optimise antigen-specific liposomal nanotherapies for in vitro stability and evaluate their biodistribution and efficacy in vivo using preclinical models of autoimmune disease. She has also developed unique expertise in creating scalable, immune-targeted delivery platforms for clinical translation through close collaboration with a Clinical Drug Manufacturing Organisation for the scale-up and manufacture of ASITI-RA, a rheumatoid arthritis antigen-specific immunotherapy.

Her broader expertise spans:

• Nanomedicine formulation and characterisation

• Translational immunology and preclinical model development (humanised mice)

• Collaborative, consumer-partnered, and clinician-led translational research

Dr Moonshi’s goal is to advance precision immunotherapies that restore immune tolerance and transform outcomes for people with autoimmune and inflammatory diseases.

Emeritus Prof Moore’s research interests include: history of Australia, Queensland, Pacific Islands, New Guinea, Papua New Guinea, and Solomon Islands,.

Emeritus Prof Moore holds a BA and PhD from James Cook University. His teaching at UQ covered Australia, Queensland, and the Pacific Islands, colonial and race relations history, and the history of gender and sexuality. He was Head of the School of History, Philosophy, Religion and Classics from 2008 to 2013.

Emeritus Prof Moore held the McCaughey Chair in History. He has been a member of the Board of the Journal of Pacific History since 1998. In 1999 he headed the Queensland team for the National Archives Founding Documents Webpage. During 2000-01 he served on a Panel of Enquiry into the restructure of the University of PNG and authored a UNESCO report on higher distance education in UPNG. In 2005 he was awarded a Cross of Solomon Islands for his work on Solomon Islands history. He was President of the Australian Association for the Advancement of Pacific Studies from 2006 to 2010 and was elected a Fellow of the Australian Academic of the Humanities in 2011.

He has contunued to research and publish on Solomon Islands and Queensland.

Associate Professor Andy Moore is a Paediatric Oncologist and Director of Research at Children's Health Queensland Hospital & Health Service (CHQ). He is also Director of the Queensland Children's Tumour Bank, a unique resource located on the Queensland Children's Hospital precinct, facilitating local, national and international collaborative research across all childhood cancer types and supporting enrolment of children on clinical trials. A/Prof. Moore's clinical and research interests focus on childhood leukaemia, particularly acute myeloid leukaemia (AML), an aggressive form of leukaemia with a poor prognosis. He also holds a number of leadership and advisory roles, including Deputy Chair of the Australian & New Zealand Childrens Haematology / Oncology Group (ANZCHOG).